149 related articles for article (PubMed ID: 37025609)
1. Evaluating the performance of the Roche FEN2 fentanyl immunoassay and its clinical implementation: The role of LDT-based mass spectrometry testing.
Menlyadiev M; Suhandynata RT; Lund K; Kelner MJ; Fitzgerald RL
J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():105-113. PubMed ID: 37025609
[TBL] [Abstract][Full Text] [Related]
2. A Comparative Analysis of Two Commonly Used FDA-Approved Immunoassays for Fentanyl Detection.
Lam KHB; Menlyadiev M; Buggs V; Parnprome S; Pesce A; Suhandynata RT; Fitzgerald RL; Song L; Metushi IG
J Appl Lab Med; 2024 Jun; ():. PubMed ID: 38831664
[TBL] [Abstract][Full Text] [Related]
3. Performance Evaluation of an Automated Fentanyl Immunoassay.
Tang MS; Lloyd M; Williams M; Farnsworth CW; Budelier MM
J Appl Lab Med; 2021 Sep; 6(5):1192-1201. PubMed ID: 34263303
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two highly sensitive benzodiazepine immunoassay lab developed tests for urine drug testing in clinical specimens.
Lund K; Menlyadiev M; Lee K; Kelner MJ; Fitzgerald RL; Suhandynata RT
J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():91-98. PubMed ID: 36937812
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Two Commercially Available Fentanyl Screening Immunoassays for Clinical Use.
Budelier MM; Franks CE; Logsdon N; Jannetto PJ; Scott MG; Roper SM; Farnsworth CW
J Appl Lab Med; 2020 Nov; 5(6):1277-1286. PubMed ID: 32674121
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Response of DRI Oxycodone Semiquantitative Immunoassay With True Oxycodone Values Determined by Liquid Chromatography Combined With Tandem Mass Spectrometry: Sensitivity of the DRI Assay at 100 ng/ml Cut-Off and Validity of Semiquantitative Value.
Dixon RB; Davis B; Dasgupta A
J Clin Lab Anal; 2016 May; 30(3):190-5. PubMed ID: 25715994
[TBL] [Abstract][Full Text] [Related]
7. Advances in fentanyl testing.
Uljon S
Adv Clin Chem; 2023; 116():1-30. PubMed ID: 37852717
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay.
Wang BT; Colby JM; Wu AH; Lynch KL
J Anal Toxicol; 2014; 38(9):672-5. PubMed ID: 25248490
[TBL] [Abstract][Full Text] [Related]
9. Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis.
Dixon RB; Dasgupta A
Ther Drug Monit; 2016 Dec; 38(6):787-790. PubMed ID: 27764026
[TBL] [Abstract][Full Text] [Related]
10. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
Puzyrenko A; Wang D; Schneider R; Wallace G; Schreiber S; Brandt K; Gunsolus IL
J Anal Toxicol; 2022 Aug; 46(7):712-718. PubMed ID: 34557900
[TBL] [Abstract][Full Text] [Related]
11. Comparison of SemiQuantitative Cotinine Values Obtained by the DRI Immunoassay and Values Obtained by a Liquid Chromatography-Tandem Mass Spectrometry-Based Method: The DRI Immunoassay is Suitable for Screening Purposes Only Because Semiquantitative Values May Be Unreliable.
Dixon RB; Dasgupta A
J Clin Lab Anal; 2016 Nov; 30(6):1106-1109. PubMed ID: 27212710
[TBL] [Abstract][Full Text] [Related]
12. An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results.
Geno KA; Badea A; Lynch KL; Jannetto P; Hubbard JA; Nerenz RD; Cervinski MA
J Appl Lab Med; 2022 Oct; 7(6):1318-1328. PubMed ID: 36036092
[TBL] [Abstract][Full Text] [Related]
13. Performance of Two Fentanyl Immunoassays against a Liquid Chromatography-Tandem Mass Spectrometry Method.
Feng S; Rutledge TJ; Manzoni M; Le T; Gardiner J; Milone M; Shaw L; Wang P
J Anal Toxicol; 2021 Feb; 45(2):117-123. PubMed ID: 32435812
[TBL] [Abstract][Full Text] [Related]
14. False-positive ethyl glucuronide immunoassay screening associated with chloral hydrate medication as confirmed by LC-MS/MS and self-medication.
Arndt T; Gierten B; Güssregen B; Werle A; Grüner J
Forensic Sci Int; 2009 Jan; 184(1-3):e27-9. PubMed ID: 19084359
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Performance of Laboratory-Developed Liquid Chromatography-Tandem Mass Spectrometry Tests and a Food and Drug Administration-Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus.
Schniedewind B; Meyer EJ; Christians U
Ther Drug Monit; 2020 Jun; 42(3):421-426. PubMed ID: 32427781
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the 25-hydroxy vitamin D assay on a fully automated liquid chromatography mass spectrometry system, the Thermo Scientific Cascadion SM Clinical Analyzer with the Cascadion 25-hydroxy vitamin D assay in a routine clinical laboratory.
Benton SC; Tetteh GK; Needham SJ; Mücke J; Sheppard L; Alderson S; Ruppen C; Curti M; Redondo M; Milan AM
Clin Chem Lab Med; 2020 Jun; 58(6):1010-1017. PubMed ID: 31851610
[TBL] [Abstract][Full Text] [Related]
17. Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty.
Mina A
J Pharmacol Toxicol Methods; 2020; 101():106649. PubMed ID: 31730939
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
[TBL] [Abstract][Full Text] [Related]
19. Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serum.
Zhang Y; Halifax JC; Tangsombatvisit C; Yun C; Pang S; Hooshfar S; Wu AHB; Lynch KL
J Mass Spectrom Adv Clin Lab; 2022 Nov; 26():1-6. PubMed ID: 36065325
[TBL] [Abstract][Full Text] [Related]
20. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
Darragh A; Snyder ML; Ptolemy AS; Melanson S
Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
